UroCareLive

CME Presentations

Prostate Cancer


Presentations


Speakers

  • Daniel J. George, MD

    Daniel J. George, MD

    Daniel J. George, MD

    Professor of Medicine and Surgery, Divisions of Medical Oncology and Urology

    Daniel J. George, MD, is a professor of medicine and surgery in the Divisions of Medical Oncology and Urology at Duke University School of Medicine in Durham, North Carolina. He also has appointments in the Duke Clinical Research Institute and the Duke Cancer Institute, where he is the director of genitourinary (GU) oncology. Dr George’s areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis. He leads the Duke site for the Department of Defense Prostate Cancer Clinical Trials Consortium, specializing in Phase I and II studies in prostate cancer. Dr George is an internationally recognized clinical researcher and thought leader in GU malignancies, with over 150 peer-reviewed publications.
  • Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    President

    Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 250 clinical trials that focus mainly on GU oncology, serves on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 125 peer-reviewed publications, several book chapters, and is a peer reviewer for Lancet Oncology, Urology, and numerous other journals. He earned his MD from Duke University Medical School.

CME Information

Optimal Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: Expert Analysis through Case Studies


LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:
  • Employ the latest NCCN and AUA clinical guidelines for prostate cancer
  • Evaluate the benefits and challenges of available treatment modalities in order to effectively sequence them into treatment plans

Acknowledgement

This activity is supported by independent medical education grants from Bayer HealthCare Pharmaceuticals Inc, Sanofi Genzyme, and Tolmar.

Tuition

Complimentary

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and PlatformQ Heath Education. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Live Activity
The Annenberg Center for Health Sciences at Eisenhower designates this live activity a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Enduring Material
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release/Expiration

Live Activity
Wednesday, May 30, 2018 from 11:00am – 12:00pm EDT.
Enduring Material
The enduring material will be available from May 30, 2018 to November 30, 2018.

Target Audience

This activity has been designed to meet the educational needs of urologists and genitourinary and medical oncologists, with a secondary audience of other health care professionals (internists, primary care physicians, physicians-in-training, oncology nurses, urology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with prostate cancer.

Estimated Time to Complete

This activity consists of one session which should take approximately 1 hour to complete.

Method Of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Facutly

Daniel J. George, MD Professor of Medicine and Surgery, Divisions of Medical Oncology and Urology Duke University School of Medicine Neal D. Shore, MD, FACS Medical Director Carolina Urologic Research Center

DISCLOSURE OF CONFLICTS OF INTEREST

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Financial Disclosures

Daniel J. George, MD Consulting Fees: Astellas, Axess Onc, Bayer, BMS, Exelixis, Innocrin, OncLive, J&J, Myovant, Pfizer, Sanofi Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Bayer, Exelixis, Sanofi Contracted Research: Acerta, AstraZeneca, Bayer, BMS, Dendreon, Exelixis, Innocrin, J&J, Millennium, Novartis, Pfizer, Sanofi Other: IDMC member, Acceleron Pharma Neal D. Shore, MD, FACS Consluting Fees: AbbVie, Amgen, AZ, BMS, Dendreon, Ferring, Genentech, Genomic Health, Inovio, Invitae, Janssen, Merck, Myriad, Nymox, Panacea, Pfizer, Roche, Sanofi-Genzyme, Tolmar Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: AbbVie, Amgen, AZ, BMS, Dendreon, Ferring, Genentech, Genomic Health, Inovio, Invitae, Janssen, Merck, Myriad, Nymox, Panacea, Pfizer, Roche, Sanofi-Genzyme, Tolmar Contracted Research: AbbVie, Amgen, AZ, BMS, Dendreon, Ferring, Genentech, Genomic Health, Inovio, Invitae, Janssen, Merck, Myriad, Nymox, Panacea, Pfizer, Roche, Sanofi-Genzyme, Tolmar The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose. Charles E. Willis, Director of Continuing Education (Annenberg Center for Health Sciences at Eisenhower), consults for Pfizer, Inc. The following PlatformQ Health Education, LLC planners and managers, Hamsa Jaganathan, PhD, and Alissa Yost, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE

(if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support: Please contact the Postgraduate Institute for Medicine at www.pimed.com. Techincal Support For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com..